{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:01:59Z","timestamp":1789682519033,"version":"4.0.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Freiburg"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>While pancreatic ductal adenocarcinoma (PDAC) carries a poor prognosis, a small fraction of patients show high microsatellite instability (MSI-H) and may respond to immune checkpoint inhibition. An MSI-H genotype is usually associated with deficiencies in the DNA mismatch-repair mechanism (MMRd). However, discordances between the mismatch-repair status by immunohistochemistry and the microsatellite status by molecular analyses have been noted. To date it is not clear whether PDAC patients with mutations in mismatch repair genes, which result in loss of protein expression (MMRd), who nonetheless retain microsatellite stability (MSS), can profit from checkpoint inhibitor therapy. Here, we present the case of a PDAC patient, diagnosed as MMRd\/MSS, who responded to checkpoint inhibitor therapy after failing two lines of chemotherapy. Our data suggest that both MMR and microsatellite status should be determined in PDAC patients and that MMRd status alone, even in an MSS phenotype, can constitute an indication for checkpoint inhibitor therapy.<\/jats:p>","DOI":"10.1007\/s00432-025-06334-3","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T17:40:19Z","timestamp":1761068419000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Response to PD-1 inhibition in MMRd\/MSS pancreatic ductal adenocarcinoma: the relevance of parallel testing"],"prefix":"10.1007","volume":"151","author":[{"given":"Heike L.","family":"Pahl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silke","family":"Lassmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"Schultheis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Rau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"B\u00f6rries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justus","family":"Duyster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Zaiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Quante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiko","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"MTB-FR Network","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,21]]},"reference":[{"key":"6334_CR1","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.annonc.2024.03.009","volume":"35","author":"M Ambrosini","year":"2024","unstructured":"Ambrosini M et al (2024) Immune checkpoint inhibitors for POLE or POLD1 proofreading-deficient metastatic colorectal cancer. Ann Oncol 35:643\u2013655. https:\/\/doi.org\/10.1016\/j.annonc.2024.03.009","journal-title":"Ann Oncol"},{"key":"6334_CR2","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.5858\/arpa.2021-0632-CP","volume":"146","author":"AN Bartley","year":"2022","unstructured":"Bartley AN et al (2022) Mismatch repair and microsatellite instability testing for immune checkpoint inhibitor therapy: guideline from the College of American Pathologists in collaboration with the Association for Molecular Pathology and Fight Colorectal Cancer. Arch Pathol Lab Med 146:1194\u20131210. https:\/\/doi.org\/10.5858\/arpa.2021-0632-CP","journal-title":"Arch Pathol Lab Med"},{"key":"6334_CR3","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-004485","author":"S Chakrabarti","year":"2022","unstructured":"Chakrabarti S et al (2022) Detection of microsatellite instability-high (MSI-H) by liquid biopsy predicts robust and durable response to immunotherapy in patients with pancreatic cancer. J Immunother Cancer. https:\/\/doi.org\/10.1136\/jitc-2021-004485","journal-title":"J Immunother Cancer"},{"key":"6334_CR4","doi-asserted-by":"publisher","DOI":"10.1200\/PO.24.00047","author":"I Fernandes","year":"2024","unstructured":"Fernandes I et al (2024) Microsatellite instability and clinical use in sarcomas: systematic review and illustrative case report. JCO Precis Oncol. https:\/\/doi.org\/10.1200\/PO.24.00047","journal-title":"JCO Precis Oncol"},{"key":"6334_CR5","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.ajhg.2016.08.016","volume":"99","author":"NM Ioannidis","year":"2016","unstructured":"Ioannidis NM et al (2016) REVEL: an ensemble method for predicting the pathogenicity of rare missense variants. Am J Hum Genet 99:877\u2013885. https:\/\/doi.org\/10.1016\/j.ajhg.2016.08.016","journal-title":"Am J Hum Genet"},{"key":"6334_CR6","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/s41379-021-00918-3","volume":"35","author":"M Jaffrelot","year":"2022","unstructured":"Jaffrelot M et al (2022) An unusual phenotype occurs in 15% of mismatch repair-deficient tumors and is associated with non-colorectal cancers and genetic syndromes. Mod Pathol 35:427\u2013437. https:\/\/doi.org\/10.1038\/s41379-021-00918-3","journal-title":"Mod Pathol"},{"key":"6334_CR7","doi-asserted-by":"publisher","first-page":"D862","DOI":"10.1093\/nar\/gkv1222","volume":"44","author":"MJ Landrum","year":"2016","unstructured":"Landrum MJ et al (2016) ClinVar: public archive of interpretations of clinically relevant variants. Nucleic Acids Res 44:D862-868. https:\/\/doi.org\/10.1093\/nar\/gkv1222","journal-title":"Nucleic Acids Res"},{"key":"6334_CR8","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.humpath.2022.06.009","volume":"132","author":"C Luchini","year":"2023","unstructured":"Luchini C, Scarpa A (2023) Microsatellite instability in pancreatic and ampullary carcinomas: histology, molecular pathology, and clinical implications. Hum Pathol 132:176\u2013182. https:\/\/doi.org\/10.1016\/j.humpath.2022.06.009","journal-title":"Hum Pathol"},{"key":"6334_CR9","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/s43018-024-00894-y","volume":"6","author":"A Marabelle","year":"2025","unstructured":"Marabelle A et al (2025) Pembrolizumab in microsatellite-instability-high and mismatch-repair-deficient advanced solid tumors: updated results of the KEYNOTE-158 trial. Nat Cancer 6:253\u2013258. https:\/\/doi.org\/10.1038\/s43018-024-00894-y","journal-title":"Nat Cancer"},{"key":"6334_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241914468","author":"M Mendiola","year":"2023","unstructured":"Mendiola M et al (2023) Comparison of methods for testing mismatch repair status in endometrial cancer. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms241914468","journal-title":"Int J Mol Sci"},{"key":"6334_CR11","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12967-024-04960-y","volume":"22","author":"ML N\u00e1dorv\u00e1ri","year":"2024","unstructured":"N\u00e1dorv\u00e1ri ML et al (2024) Comparison of standard mismatch repair deficiency and microsatellite instability tests in a large cancer series. J Transl Med 22:150. https:\/\/doi.org\/10.1186\/s12967-024-04960-y","journal-title":"J Transl Med"},{"key":"6334_CR12","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s10689-013-9616-0","volume":"12","author":"JP Plazzer","year":"2013","unstructured":"Plazzer JP et al (2013) The insight database: utilizing 100 years of insights into Lynch syndrome. Fam Cancer 12:175\u2013180. https:\/\/doi.org\/10.1007\/s10689-013-9616-0","journal-title":"Fam Cancer"},{"key":"6334_CR13","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/cncr.35030","volume":"130","author":"CJ Riedinger","year":"2024","unstructured":"Riedinger CJ et al (2024) Characterization of mismatch-repair\/microsatellite instability-discordant endometrial cancers. Cancer 130:385\u2013399. https:\/\/doi.org\/10.1002\/cncr.35030","journal-title":"Cancer"},{"key":"6334_CR14","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1093\/annonc\/mdw542","volume":"28","author":"E Stelloo","year":"2017","unstructured":"Stelloo E et al (2017) Practical guidance for mismatch repair-deficiency testing in endometrial cancer. Ann Oncol 28:96\u2013102. https:\/\/doi.org\/10.1093\/annonc\/mdw542","journal-title":"Ann Oncol"},{"key":"6334_CR15","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ejca.2023.04.012","volume":"188","author":"J Ta\u00efeb","year":"2023","unstructured":"Ta\u00efeb J et al (2023) Efficacy of immune checkpoint inhibitors in microsatellite unstable\/mismatch repair-deficient advanced pancreatic adenocarcinoma: an AGEO European cohort. Eur J Cancer 188:90\u201397. https:\/\/doi.org\/10.1016\/j.ejca.2023.04.012","journal-title":"Eur J Cancer"},{"key":"6334_CR16","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1093\/genetics\/148.4.1637","volume":"148","author":"A Umar","year":"1998","unstructured":"Umar A et al (1998) Functional overlap in mismatch repair by human MSH3 and MSH6. Genetics 148:1637\u20131646. https:\/\/doi.org\/10.1093\/genetics\/148.4.1637","journal-title":"Genetics"},{"key":"6334_CR17","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1200\/jco.22.02462","volume":"41","author":"P Vikas","year":"2023","unstructured":"Vikas P et al (2023) Mismatch repair and microsatellite instability testing for immune checkpoint inhibitor therapy: ASCO endorsement of college of American pathologists guideline. J Clin Oncol 41:1943\u20131948. https:\/\/doi.org\/10.1200\/jco.22.02462","journal-title":"J Clin Oncol"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-025-06334-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-025-06334-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-025-06334-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T19:38:52Z","timestamp":1765654732000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-025-06334-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":17,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6334"],"URL":"https:\/\/doi.org\/10.1007\/s00432-025-06334-3","relation":{},"ISSN":["1432-1335"],"issn-type":[{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,21]]},"assertion":[{"value":"13 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"302"}}